Cephalon (CEPH) Trades Down Slightly After Rejecting Valeant's (VRX) Offer
Tweet
Share
E-mailGet Alerts CEPH Hot Sheet
Join SI Premium – FREE
Cephalon, Inc. (NASDAQ: CEPH) is trading down slightly to $76.76 after formally rejecting a Valeant Pharmaceuticals (NYSE: VRX) $73 takeover bid. Shares closed at $77.37 today.
Valent is down 0.9% to $53.50.
Valent is down 0.9% to $53.50.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nscale targets up to $3B in US IPO as soon as September - Bloomberg
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Trump admin taps former JPMorgan Chase exec Matt Zames to advise social security agency - CNBC
Create E-mail Alert Related Categories
Mergers and Acquisitions, Trader Talk, Trading HaltsRelated Entities
Valeant Pharmaceuticals/Cephalon, Inc.Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
